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Objective: To evaluate the change of ovarian reserve after unilateral laparoscopic ovarian cystectomy
(LOC) in the early postoperative period between patients divided according to histologic diagnosis of cyst
type.
Materials and Methods: Sixty-ﬁve patients who were undergoing unilateral LOC for benign ovarian
disease were included in this study. All participants were divided into three groups according to his-
tologic diagnosis: endometrioma (n¼ 26), mature teratoma (n¼ 24), and other benign cyst (n¼ 15).
Serum samples were collected preoperatively and 3-days postoperatively and assayed for antiMüllerian
hormone (AMH) levels, and the changes between the two samples were analyzed.
Results: Preoperative AMH levels were not signiﬁcantly different between the three groups. On post-
operative Day 3 AMH levels of all three groups were signiﬁcantly reduced compared with preoperative
AMH levels. The rates of decline of AMH levels after LOC in patients with endometrioma (26.37± 20.70%)
and in those with teratoma (28.25 ± 22.16%) were both signiﬁcantly higher than those with other benign
cyst (12.03± 18.56%). No statistically signiﬁcant differences were found in the rate of decline of AMH
levels between patients with endometrioma and teratoma. Decline of AMH after LOC was not signiﬁ-
cantly correlated with age, body mass index, the size of cyst, or preoperative AMH levels.
Conclusion: Our results suggest that ovarian reserve is reduced after unilateral LOC in the early post-
operative period, and that the postoperative decline of AMH levels after LOC is similar between patients
with endometrioma and those with mature teratoma.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
The ovarian reserve, which refers to the size of the nongrowing,
or resting, primordial follicle population in the ovaries, presumably
determines the number of growing follicles and the “quality” or
reproductive potential of their oocytes [1,2]. Age is the main
determinant of ovarian reserve, but other iatrogenic factors, such as
surgery, radiation, chemotherapy, and other systemic gonadotoxic
medication, also cause a decrease of ovarian reserve [1e4]. A
number of methods have been used to measure ovarian reserve
over the years [1e3], and antiMüllerian hormone (AMH) isand Gynecology, Inje Univer-
aeundae-gu, Busan 612-030,
bstetrics & Gynecology. Published bconsidered the most useful marker of ovarian reserve among these
ovarian reserve tests, as it is the only marker of ovarian reserve that
is both menstrual cycle independent and easily measurable [4e6].
Laparoscopic ovarian cystectomy (LOC) is one of the most
commonly and easily performed gynecological surgeries, and it is a
valid method for elucidating the serial change of serum AMH,
which reﬂects the changes of ovarian reserve after LOC [7].
Endometrioma (also known as an ovarian endometriotic cyst) is
a pseudocyst formed by invagination from endometriotic implants
in most cases, and a large endometrioma may develop as a result of
the secondary involvement of a functional ovarian cyst in the
process of endometriosis [8e10]. Resection of endometrioma was
frequently associated with loss of follicles and damage to the
ovarian stroma [9]. A number of studies reported an association
between LOC for endometrioma and the postoperative reduction of
ovarian reserve [7,11e15]. Several studies reported that they Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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sented by serial measurement of serum AMH levels, was more
pronounced compared with nonendometriotic cyst [7,12,13], but
one study with a relatively large sample size reported that there
was no signiﬁcant difference in the decline of ovarian reserve after
LOC between the endometrioma group and the other non-
endometriotic benign ovarian cyst group [15]. A deﬁnitive study on
the difference in ovarian reserve change after LOC according to a
histologic diagnosis of benign nonendometriotic ovarian cyst is still
lacking. Mature cystic teratoma is a benign ovarian tumor, and it is
one of the most common indications for LOC. To date, there have
been no reports directly comparing AMH decline after LOC between
patients with endometrioma and those with teratoma.
The aim of this study was to evaluate whether serum AMH
levels were reduced immediately after unilateral LOC. We also
aimed to evaluate the differences of the change of ovarian reserve
immediately after LOC according to histologic diagnosis of ovarian
cyst type, particularly between patients with endometrioma and
those with mature cystic teratoma.
Materials and methods
Participants
This study was approved by the Institutional Review Board of
Inje University Haeundae Paik Hospital, Busan, Korea. Patients aged
18e45 years with regular menstrual cycles (21e35 days) who ﬁrst
visited Inje University Haeundae Paik Hospital and underwent
scheduled unilateral LOC between October 2010 and December
2013 were recruited for this study. After a complete medical history
and taking baseline values from physical examination, we collected
data including age, weight, height, and body mass index (BMI).
Individuals were excluded from this study if they had a history of
previous uterine or adnexal surgery for gynecologic pathology
except: (1) cesarean section; (2) clinical or ultrasonographic sus-
picion of ovarian malignancy; (3) any hormone treatment during
the previous 6 months; (4) other endocrine diseases such as dia-
betes mellitus and thyroid or adrenal disease; and (5) polycystic
ovarian syndrome. Patients who had bilateral ovarian lesions were
also excluded. Finally, a total of 65 patients were included in the
present study.
The patients were divided into three groups according to the
histologic diagnosis of cyst type conﬁrmed by pathologists after
laparoscopic surgery: endometrioma, mature cystic teratoma, or
other benign cyst. A total of 26 patients were diagnosed with
ovarian endometrioma (Group 1), 24 patients were diagnosed with
mature cystic teratoma (Group 2), and 15 patients were diagnosed
with other benign cyst (Group 3). The speciﬁc histologic diagnoses
of patients with other benign cyst were serous cystadenoma
(n¼ 7), mucinous cystadenoma (n¼ 6), and luteal cyst (n¼ 2).
Operative techniques
All of the laparoscopic ovarian operations were performed by
the same gynecologist with> 10 years of experience in laparoscopic
surgery. After an 11-mm subumbilical trochar insertion was per-
formed, pneumoperitoneum was established with CO2 gas until
intra-abdominal pressure reached 12 mmHg under general anes-
thesia. Next, two 5-mm ancillary trocars were inserted in the left
lower quadrant and suprapubic area. Following telescopic entry,
the ovarian cyst was removed with a monopolar cautery and
grasping forceps after identifying the cleavage plane between the
capsule of the cyst and the normal ovarian tissue. Then, minimal
hemostasis with bipolar forceps was performed to prevent thermal
damage to normal ovarian tissue without laparoscopic suture. Afterremoval of the ovarian tumor, histologic conﬁrmations of all the
specimens were made.
Measurement of serum AMH level
Blood samples were collected from the antecubital vein in all
patients, in accordance with the Declaration of Helsinki guidelines,
and serum samples were obtained by centrifugation for determi-
nation of serum AMH level. Serum samples were collected preop-
eratively and 3-days postoperatively and assayed for AMH levels.
Serum AMH level was measured using a commercially available
enzyme-linked immunosorbent assay kit (AMH Gen II assay;
Beckman Coulter Inc., Brea, CA, USA). The lowest detection limit
was 0.08 ng/mL, and the intra- and interassay coefﬁcients of vari-
ation for the AMH assay were both below 8.0%.
The changes between the two samples were analyzed. The rate
of decline of AMH levels was calculated using the following
formula:
[(preoperative AMH level  postoperative Day 3 AMH level)/
(preoperative AMH levels)] 100 (%). (1)
Measurement of the size of ovarian cyst by ultrasound
Transvaginal or transrectal ultrasound examination was per-
formed on all participants with a Voluson S7 (General Electric
Systems, Seongnam, Korea) equipped with a 7-MHz transvaginal
transducer during the week before surgery. The size of ovarian cyst
(cm) was calculated in a sagittal cross section as follows:
Size of ovarian cyst (cm)¼ [(vertical diameter of cyst)þ (horizontal
diameter of cyst)]/2 (2)
Statistical analyses
All data are expressed as mean± standard deviation. All data
analyses were performed using SPSS (version 12.0; SPSS Inc., Chi-
cago, IL, USA). One-way analysis of variance test followed by Tukey
post-hoc test was performed for comparisons of clinical parameters
and laboratory serum AMH levels between the groups divided
based on histologic diagnosis of cyst type. For comparison between
preoperative and postoperative serumAMH levels, paired samples t
test or Wilcoxon signed-rank test was used. The rate of decline of
AMH levels was compared between each of the three groups using
the ManneWhitney U test. The correlations between the reduction
of AMH levels and other parameters were evaluated using Pear-
son’s correlation coefﬁcients and a linear regression analysis. A p
value < 0.05 was considered signiﬁcant for all analyses.
Results
Table 1 shows the baseline clinical characteristics in the three
groups. The mean age of the total participants was 31.14± 7.58
years, the mean height was 162.88± 4.49 cm, the mean body
weight was 56.69± 9.80 kg, the mean BMI was 21.37± 3.58 kg/m2,
and the mean size of ovarian cyst was 5.02± 2.75 cm. There were
signiﬁcant differences in age between patients with ovarian
endometrioma (Group 1) compared with the other two groups
(Table 1). The mean size of ovarian cysts in the endometrioma
group was smaller compared with the other two groups, but the
difference was not statistically signiﬁcant. The mean number of
cysts resected per ovary in patients in Group 1 (1.19± 0.40) was not
signiﬁcantly different from that in those in Group 2 (1.04± 0.20)
and Group 3 (1.07± 0.26).
Table 1
Comparisons of clinical characteristics between three groups according to histologic
diagnosis.
Group 1
(n¼ 26)
Group 2
(n¼ 24)
Group 3
(n¼ 15)
p
Age (y) 34.96± 5.16* 28.46± 7.41* 28.80± 8.92* 0.003
Height (cm) 162.37± 4.49 163.23± 5.17 163.19± 3.39 0.765
Body weight (kg) 54.63± 5.60 57.68± 9.60 58.70± 14.76 0.370
Body mass index (kg/m2) 20.77± 2.43 21.64± 3.49 21.99± 5.19 0.524
Size of ovarian cyst (cm) 4.51± 1.99 5.32± 3.68 5.41± 2.11 0.485
Data are expressed as mean± standard deviation.
* p< 0.05 by Tukey post-hoc test and analysis of variance.
Group 1¼ ovarian endometrioma; Group 2¼ ovarian mature cystic teratoma;
Group 3¼ other benign ovarian cyst.
Figure 1. Rate of decline of antiMüllerian hormone (AMH) levels (%) after laparoscopic
ovarian cystectomy among the three groups according to histologic diagnosis.
* p < 0.05 by Tukey post-hoc test.
Table 3
Correlations coefﬁcients between the rate of decline of antiMüllerian hormone
(AMH) levels and other parameters in the three groups according to histologic
diagnosis.
Age (y) Body mass
index (kg/m2)
Size of
ovarian
cyst (cm)
Preoperative
AMH (ng/mL)
Total participants (n¼ 65)
r 0.083 e0.114 0.055 0.045
p 0.509 0.367 0.662 0.721
Group 1 (n¼ 26)
r 0.016 e0.091 -0.043 0.123
p 0.940 0.743 0.835 0.551
Group 2 (n¼ 24)
r 0.064 e0.018 0.110 e0.102
p 0.766 0.933 0.608 0.635
Group 3 (n¼ 15)
r 0.033 e0.200 0.246 0.362
p 0.907 0.474 0.377 0.185
Group 1¼ ovarian endometrioma; Group 2¼ ovarian mature cystic teratoma;
Group 3¼ other benign ovarian cyst; r¼ Pearson’s correlation coefﬁcient.
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5.63± 3.09 ng/mL. The mean preoperative AMH level in patients
with endometriosis was lower than in the other two groups, but
these differences were not statistically signiﬁcant (Table 2). Post-
operative Day 3 serum AMH levels of total participants
(4.42± 2.36 ng/mL) were signiﬁcantly reduced compared with
preoperative AMH levels. All of the postoperative Day 3 AMH levels
in patients with endometrioma (3.59± 1.83 ng/mL), teratoma
(4.39± 2.64 ng/mL), and other benign cysts (5.39± 2.57 ng/mL)
were also signiﬁcantly reduced compared with preoperative levels
within the same group (p< 0.001 in Group 1; p< 0.001 in Group 2;
and p¼ 0.015 in Group 3).
The mean value of the rate of decline of AMH levels after uni-
lateral LOC of all participants was 23.76± 21.49%. Themean value of
the rate of decline of AMH levels after unilateral LOC in patients
with teratoma (28.25± 22.16%) was similar to that in those with
endometrioma (26.37± 20.70%; Table 2). The rate of decline of
AMH level of unilateral LOC in patients with other benign cysts was
signiﬁcantly lower compared with both patients with endome-
trioma and those with mature cystic teratoma (Table 2 and
Figure 1).
In Table 3, no signiﬁcant correlations were found between the
rate of decline of AMH level after LOC and other parameters
including age, BMI, ovarian cyst size, and preoperative AMH level
irrespective of histologic diagnosis.
Discussion
LOC is a well-established technique and is used as the treatment
of choice of surgical excision of benign symptomatic ovarian [16,17].
The ﬁrst aim of this study was to evaluate whether ovarian reserveTable 2
Comparisons of serum antiMüllerian hormone (AMH) levels between three groups
according to histologic diagnosis.
Group 1 Group 2 p
Preoperative AMH (ng/mL) 4.97± 2.66 5.88± 3.17 0.308
Postoperative d 3 AMH (ng/mL) 3.59± 1.83 4.39± 2.64 0.367
Rate of decline of AMH levels (%) 26.37± 20.70 28.25± 22.16 0.662
Group 1 Group 3
Preoperative AMH (ng/mL) 4.97± 2.66 6.39± 3.61 0.253
Postoperative d 3 AMH (ng/mL) 3.59± 1.83 5.39± 2.57 0.028
Rate of decline of AMH levels (%) 26.37± 20.70 12.03± 18.56 0.037
Group 2 Group 3
Preoperative AMH (ng/mL) 5.88± 3.17 6.39± 3.61 0.721
Postoperative d 3 AMH (ng/mL) 4.39± 2.64 5.39± 2.57 0.283
Rate of decline of AMH levels (%) 28.25± 22.16 12.03± 18.56 0.013
Data are expressed as mean± standard deviation. The p value was determined by
ManneWhitney test.
Group 1¼ ovarian endometrioma; Group 2¼ ovarian mature cystic teratoma;
Group 3¼ other benign ovarian cyst.reduced immediately after unilateral LOC by serial measurement of
serum AMH levels, and the result is that unilateral LOC signiﬁcantly
reduced ovarian reserve immediately after surgery irrespective of
pathologic results.
AMH is regarded as the marker of choice for ovarian reserve in
female reproduction [4e6,18,19]. The serum level of AMH in
women with normal cycles declines with age and becomes unde-
tectable after menopause [1,4]. van Rooij et al [18] noted that serum
AMH concentrations showed the best consistency over time among
the various ovarian reserve markers, and concluded that serum
AMH represents the best endocrine marker to assess the age-
related decline of reproductive capacity.
AMH can also be a useful marker for women planning to un-
dergo adnexal surgery which is expected to cause the reduction of
ovarian reserve [7,20]. LOC for endometrioma is associated with a
signiﬁcant reduction in ovarian reserve [12e14,21e23]. Var et al
[21] noted that both antral follicle count and ovarian volume
decreased after LOC with bilateral endometriomas, and Horikawa
et al [22] reported that unilateral LOC for endometrioma reduces
the frequency of ovulation after surgery. Recently, two meta-
analyses have shown that AMH levels are signiﬁcantly reduced
after surgical excision of endometriomas [11,24], and the Euro-
pean Society of Human Reproduction and Embryology recom-
mends that clinicians should counsel women with endometrioma
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Lee et al [12] suggested two possible explanations for the reduc-
tion of ovarian reserve after LOC for ovarian endometriotic cyst.
Firstly, excision using the stripping technique can result in inad-
vertent removal of ovarian tissue and a decreased ovarian reserve
[23,26]. The resected side of the capsule of endometrioma, which
is the invaginated cortex itself, was attached to the vascular-rich
ovarian stroma and the elongated corpus albicans, and easy
removal of the cyst capsule was associated with more loss of
unaffected ovarian follicles and stroma [9]. Secondly, surgery can
induce vascular impairment, inﬂicting damage to ovarian tissue.
However, second hypothesis is in disagreement with the previous
report which showed no difference in stromal blood ﬂow between
the operated and intact ovaries [27]. In addition, laparoscopic
bipolar electrocoagulation was associated with a signiﬁcant
reduction in ovarian reserve, which result was not seen in lapa-
rotomic hemostatic sutures [28].
Performance of LOC for nonendometriotic ovarian cyst also can
cause a signiﬁcant reduction of serum AMH levels [7,13,15,29].
Whether changes in the ovarian reserve after LOC for ovarian endo-
metriotic cysts are different fromchanges for nonendometriotic cysts
remains controversial. Some authors have reported that the post-
operative decline of serum AMH level is more pronounced in the
removal of endometriomas compared with nonendometriotic cysts
[7,13,23,30], but Kwon et al [15] asserted that the rate of decline of
AMH levels after surgery was similar between an endometrioma
group and a benign nonendometriotic cyst group.
That all of the nonendometriotic ovarian cysts are currently
united into one category could be problematic. Mature cystic tera-
tomas, also called dermoid cysts, constitute some 10e13% of all
ovarian tumors and are themost common ovarian germ cell tumors
[31]. LOC for mature teratoma of the ovary is, in general, considered
to be a more difﬁcult procedure in terms of preserving normal
ovarian tissue comparedwith operations on other simple cysts such
as serous or mucinous cystadenoma and functional cysts [32].
Spillage of contents of teratoma during LOC could potentially dam-
age the remaining ovarian tissue. Furthermore, ovarian torsion is
more prevalent in patients with teratoma, which could be related to
the decrease of the ovarian reserve by the interruption of ovarian
blood ﬂow. It is therefore reasonable to divide nonendometriotic
cysts into two categories in the assessment of decline of ovarian
reserve after LOC: teratomas and other benign simple cysts. As far as
we know, only one study has reported on the difference of AMH
decline after LOC between patients with teratoma and simple
ovariancystgroup [33]. To thebestof ourknowledge, our study is the
ﬁrst to report on the issues of differences in AMH decline after LOC
betweenpatientswith endometrioma and thosewith teratoma, and
we found that the decline of AMH levels after LOC in patients with
teratoma was similar to that of patients with endometrioma.
In the present study, AMH decline after LOC was not correlated
with other parameters such as age, BMI, ovarian cyst size, or preop-
erative AMH level. The postoperative decline in serum AMH in pa-
tientswith endometrioma agreedwith the bilaterality demonstrated
in previous studies [14,15,20]. Hirokawa et al [20] reported that the
rate of decline in the serum AMH levels after LOC was not correlated
with age, cyst diameter, blood loss during the operation, or the
number of follicles removed in the specimens. These results are
consistent both with the present study and Kwon et al’s [15] study.
There may be questions about whether an AMH measurement
3-days postoperatively was too early to detect any change of
ovarian reserve after surgery. Most previous studies performed
postoperative serial AMH measurements at least 1 week after
surgery. Griesinger et al [34], however, reported that serum AMH
levels in premenopausal women undergoing a total abdominal
hysterectomy plus bilateral salpingo-oophorectomy dropped to0.08 ng/mL (minimum detection limit) within 84 hours following
surgery. Besides, all postoperative Day 3 serum AMH levels of the
14 patients who received bilateral oophorectomy were, without
exception, below the lowest detection limit according to our hos-
pital’s preliminary data (data not published). These results could
justify the postoperative Day 3 sampling for detection of the
decrease of serum AMH level after surgery, and we hypothesized
that 3 days after the operation is enough time to assess the early
reduction of ovarian reserve after laparoscopic adnexal surgery by
the serial AMH measurements.
In the present study, preoperative AMH levels in patients with
endometriosis (4.97± 2.66 ng/mL) were lower than those in the
other two groups (5.88± 3.17 ng/mL in those with teratoma, and
6.39± 3.61 ng/mL in those with other benign cysts), but, despite the
higher age shown in endometrioma group, the differences were not
statistically signiﬁcant. These results were contrary to other studies
which noted that ovarian endometrioma itself is associated with a
signiﬁcant reduction of ovarian reserve compared with normal
controls [14,35,36], but were consistent with Kitajima et al [30], who
reported no signiﬁcant difference in preoperative AMH levels be-
tween patients with endometrioma and those with non-
endometriotic control cysts. PreoperativeAMH levels in the teratoma
groupwerenotdifferent fromthose in theotherbenigncystsgroup in
this study, a ﬁnding consistent with the results of Kim et al [36].
Our study had some limitations stemming mainly from its
retrospective study design, small sample size, and short-term
period of study design. We were also unable to adjust some crit-
ical confounders in the present study, such as difﬁculties in strip-
ping during LOC and magnitude of coagulation use in individual
patients, as comparing these variables semiquantitatively is
difﬁcult.Conclusion
In summary, our results suggest that ovarian reserve is reduced
immediately after unilateral LOC, and immediate postoperative
decline of AMH levels after LOC is higher in patients with endo-
metrioma and mature cystic teratoma compared with other benign
cysts. Of primary importance, this study is the ﬁrst report on
whether AMH decline after LOC is different between patients with
endometrioma and those with teratoma. We found no differences
in the rate of decline between the two groups. Further prospective
large-scale trials to clarify the long-term effects of LOC on fertility
are needed.Conﬂicts of interest
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